MIACH Orthopaedics, Inc. is a privately held company located in Boston, Massachusetts, dedicated to developing bio-engineered surgical implants for connective tissue repair. The company's initial focus is on the Bridge-Enhanced ACL Repair (BEAR) technology as a viable alternative to conventional ACL reconstruction for patients who have sustained an ACL injury. The BEAR technology was pioneered by Martha Murray, M.D., at the Boston Children's Hospital Department of Orthopaedic Surgery with initial research funding provided by the NFL Players Association, Boston Children's Hospital and the National Institutes of Health.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/17/18 | $22,500,000 | Series A |
Amzak Capital Management DSM Venturing NFL Players Association | undisclosed |
